48 related articles for article (PubMed ID: 24369160)
1. [Outcome of children and adolescents with Burkitt lymphoma and diffuse large B cell lymphoma treated with a modified NHL-BFM-90 protocol].
Sun XF; Zhen ZJ; Xia Y; Lin SX; Zhu J; Wang J; Lu SY; Sun FF; Chen Y; Zhang F; Cai RQ; Li PF
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1032-7. PubMed ID: 24369160
[TBL] [Abstract][Full Text] [Related]
2. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
Mori T; Osumi T; Kada A; Ohki K; Koga Y; Fukano R; Fujita N; Mitsui T; Mori T; Saito AM; Nakazawa A; Kobayashi R; Sekimizu M
Eur J Haematol; 2024 Apr; 112(4):585-593. PubMed ID: 38112205
[TBL] [Abstract][Full Text] [Related]
3. Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.
Jakobsen LH; Ellin F; Smeland KB; Wästerlid T; Christensen JH; Jørgensen JM; Josefsson PL; Øvlisen AK; Holte H; Blaker YN; Grauslund JH; Bjørn J; Molin D; Lagerlöf I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
Br J Haematol; 2020 May; 189(4):661-671. PubMed ID: 32017050
[TBL] [Abstract][Full Text] [Related]
4. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.
Yanik EL; Shiels MS; Smith JM; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
Cancer; 2017 Dec; 123(23):4663-4671. PubMed ID: 28759103
[TBL] [Abstract][Full Text] [Related]
5. Optimal dosage of rituximab for children with Burkitt lymphoma.
Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
[TBL] [Abstract][Full Text] [Related]
6. Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon.
Hesseling PB; Afungchwi GM; Njodzeka BW; Wharin P; Kouya FN; Kruger M
PLoS One; 2024; 19(3):e0299777. PubMed ID: 38466670
[TBL] [Abstract][Full Text] [Related]
7. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.
Al Sbihi A; Manasrah N; Sano D; Lonardo S
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33879463
[TBL] [Abstract][Full Text] [Related]
8. A Case Series of diffuse large B-cell lymphoma and burkitt lymphoma presenting with peritoneal lymphomatosis.
Flores E; Aydin N; Vu D; Misra S
Int J Surg Case Rep; 2016; 28():262-265. PubMed ID: 27756028
[TBL] [Abstract][Full Text] [Related]
9. Presentation and Outcomes of Childhood Cancer Patients at Uganda Cancer Institute.
Mutyaba I; Wabinga HR; Orem J; Casper C; Phipps W
Glob Pediatr Health; 2019; 6():2333794X19849749. PubMed ID: 31205984
[No Abstract] [Full Text] [Related]
10. [Efficacy and safety of rituximab in children and adolescents with mature B-cell non-Hodgkin's lymphoma: a Meta analysis].
Li BY; Han YH; Yin CY; DU WC; Li YF; Wang YC
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):51-59. PubMed ID: 36655664
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
Wang YC; DU WC; Yin CY; Gong X; Li YF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):561-565. PubMed ID: 35644197
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V; Aupérin A; Pillon M; Burke GAA; Barkauskas DA; Wheatley K; Delgado RF; Alexander S; Uyttebroeck A; Bollard CM; Zsiros J; Csoka M; Kazanowska B; Chiang AK; Miles RR; Wotherspoon A; Adamson PC; Vassal G; Patte C; Gross TG; ;
N Engl J Med; 2020 Jun; 382(23):2207-2219. PubMed ID: 32492302
[TBL] [Abstract][Full Text] [Related]
13. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4.
Zhen Z; Zhu J; Wang J; Lu S; Sun F; Huang J; Sun X
Pediatr Hematol Oncol; 2020 Sep; 37(6):489-499. PubMed ID: 32364412
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children.
Zhu J; Zhen Z; Wang J; Sun F; Lu S; Huang J; Zhang Y; Sun X
Pediatr Investig; 2021 Jun; 5(2):112-117. PubMed ID: 34179707
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
Pei Y; Li Y; Liang Y; Xu L; Huang X; Li Y; Tang W; Jiang X
Int J Clin Pharm; 2020 Dec; 42(6):1440-1446. PubMed ID: 32974856
[TBL] [Abstract][Full Text] [Related]
16. Massive Hydrothorax and Ascites as the Primary Manifestation of Infection With
Liang Y; He X; Wang T; Chen Y; Huang H; Tang W; Li Y
Front Pediatr; 2020; 8():254. PubMed ID: 32509714
[No Abstract] [Full Text] [Related]
17. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
[No Abstract] [Full Text] [Related]
18. [Clinical features and prognosis of children with mature B-cell non-Hodgkin's lymphoma: an analysis of 28 cases].
Chen ZS; Zheng YZ; Chen YQ; Gao QL; Li J; Shen JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jun; 20(6):470-474. PubMed ID: 29972121
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological study of sporadic Burkitt lymphoma in children.
Huang H; Liu ZL; Zeng H; Zhang SH; Huang CS; Xu HY; Wu Y; Zeng ST; Xiong F; Yang WP
Chin Med J (Engl); 2015 Feb; 128(4):510-4. PubMed ID: 25673455
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
